Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Sequential Chemo with PBSC for Advanced Ovarian Cancer
NCT00003944Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Aug 1998
- Primary completion
- Dec 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by Fox Chase Cancer Center. Started Aug 1998; status: completed.
02
Drugs
topotecan
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00003944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003944.